Literature DB >> 6165462

Preferential damage of active chromatin by bleomycin.

M T Kuo.   

Abstract

Preferential sensitivity of specific genes in chromatin to the action of bleomycin in different cell types was investigated using restriction enzyme digestion of DNA from drug-treated nuclei in combination with the Southern blotting procedure. The results show that the highly active ovalbumin gene in laying hen oviduct nuclei is more sensitive than the inactive globin gene to the digestion by bleomycin. Conversely, in red blood cells, bleomycin preferentially destroys the globin gene but not the ovalbumin gene. Therefore, bleomycin, like nucleases, can preferentially destroy DNA sequences in chromatin with open configuration, although the mode of action of this drug on DNA is drastically different from those of known nucleases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165462

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Gamma rays and bleomycin nick DNA and reverse the DNase I sensitivity of beta-globin gene chromatin in vivo.

Authors:  B Villeponteau; H G Martinson
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

Review 2.  Mechanisms of target selection by DNA-damaging chemicals: studies with enediyne anticancer drugs.

Authors:  P C Dedon
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Site specificity of bleomycin cleavage in purified and intracellular simian virus 40 DNA.

Authors:  J E Grimwade; E B Cason; T A Beerman
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

4.  Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition.

Authors:  Alexander Koshkaryev; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Cancer Lett       Date:  2012-06-25       Impact factor: 8.679

5.  Growth phase dependency of chromatin cleavage and degradation by bleomycin.

Authors:  C W Moore; C S Jones; L A Wall
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

6.  DNA damage-inducible and RAD52-independent repair of DNA double-strand breaks in Saccharomyces cerevisiae.

Authors:  C W Moore; J McKoy; M Dardalhon; D Davermann; M Martinez; D Averbeck
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

7.  The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells.

Authors:  Vincent Murray; Jon K Chen; Anne M Galea
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

8.  Condensation of chromatin into chromosomes preserves an open configuration but alters the DNase I hypersensitive cleavage sites of the transcribed gene.

Authors:  M T Kuo; B Iyer; R J Schwarz
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

9.  Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.

Authors:  Dragana Ahel; Zuzana Horejsí; Nicola Wiechens; Sophie E Polo; Elisa Garcia-Wilson; Ivan Ahel; Helen Flynn; Mark Skehel; Stephen C West; Stephen P Jackson; Tom Owen-Hughes; Simon J Boulton
Journal:  Science       Date:  2009-08-06       Impact factor: 47.728

10.  Free-radical-mediated DNA binding.

Authors:  P J O'Brien
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.